Dechra Pharmaceuticals plc 17.1% Potential Upside Indicated by HSBC

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Dechra Pharmaceuticals plc using EPIC/TICKER code (LON:DPH) has had its stock rating noted as ‘Initiates/Starts’ with the recommendation being set at ‘BUY’ this morning by analysts at HSBC. Dechra Pharmaceuticals plc are listed in the Health Care sector within UK Main Market. HSBC have set their target price at 2770 GBX on its stock. This is indicating the analyst believes there is a potential upside of 17.1% from the opening price of 2366 GBX. Over the last 30 and 90 trading days the company share price has increased 24 points and increased 218 points respectively. The 1 year high stock price is 3180.48 GBX while the year low stock price is currently 1992 GBX.

Dechra Pharmaceuticals plc has a 50 day moving average of 2,266.21 GBX and the 200 Day Moving Average price is recorded at 2,548.05. There are currently 102,567,632 shares in issue with the average daily volume traded being 259,618. Market capitalisation for LON:DPH is £2,457,002,365 GBP.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search